Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on ReposiTrak's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into ReposiTrak's regulatory disclosures and financial reporting.
ReposiTrak, Inc. insider trading disclosure: Randall K. Fields, the company’s Chief Executive Officer, director, and 10% owner, reported automatic sales of ReposiTrak common stock executed by RK Fields Charitable 2022, LLC under a prearranged Rule 10b5-1 trading plan.
The charitable LLC sold 3,000 shares on February 2, 2026 at a weighted average price of $10.4754 per share and 4,500 shares on February 4, 2026 at a weighted average price of $10.6195 per share. Following these transactions, the LLC held 119,500 and then 115,000 shares, respectively, while Fields also reported substantial additional direct and indirect beneficial ownership in common and Series B preferred stock.
ReposiTrak, Inc. insider activity shows stock sales by an entity affiliated with CEO, director and 10% owner Randall K. Fields. RK Fields Charitable 2022, LLC sold 2,500 common shares on February 2, 2026 at a weighted average price of $11.0061 and 5,000 shares on February 4, 2026 at a weighted average price of $10.4697. These automatic sales were made under a pre-arranged Rule 10b5-1 trading plan established to help meet charitable commitments. After these transactions, the LLC still held 122,500 shares, while Fields also reported direct ownership of 3,483,955 common shares and additional indirect holdings through Riverview Financial Corp., his spouse, Fields Management, Inc., and Series B preferred stock interests.
ReposiTrak, Inc. received an updated ownership disclosure from Handelsbanken Fonder, a Swedish mutual fund manager, on an amended Schedule 13G. As of December 31, 2025, Handelsbanken Fonder reported beneficial ownership of 1,177,900 shares of ReposiTrak common stock, representing 6.4% of the class.
The firm reports sole voting and dispositive power over all of these shares and no shared power with others. It certifies that the shares were acquired and are held in the ordinary course of business as a mutual fund complex, and not for the purpose of influencing control of ReposiTrak.
ReposiTrak, Inc.’s chief executive officer, director, and 10% owner Randall K. Fields reported an automatic sale of common stock by an affiliated charitable entity. On January 26, 2026, RK Fields Charitable 2022, LLC sold 7,500 shares of ReposiTrak common stock at a weighted average price of $11.0742 per share under a pre-arranged Rule 10b5-1 trading plan established to help meet charitable commitments. After this sale, RK Fields Charitable 2022, LLC held 130,000 common shares. Fields also reported 3,483,955 common shares held directly, and indirect common holdings including 615,260 shares through Riverview Financial Corp., 30,667 shares by his spouse, and 333,643 shares through Fields Management, Inc., plus Series B Preferred Stock held indirectly via Riverview Financial Corp. and his spouse.
ReposiTrak, Inc. insider holdings data show that RK Fields Charitable 2022, LLC, an entity associated with CEO, director and 10% owner Randall K. Fields, sold common stock in two Rule 10b5-1 plan transactions. The LLC sold 2,500 shares of common stock on January 20, 2026 at a weighted average price of $10.9697, and 5,000 shares on January 21, 2026 at a weighted average price of $10.9106. These sales were made under a pre-established Rule 10b5-1 trading plan adopted by Fields in his capacity as trustee of the 2022 RK Fields Charitable Remainder Unitrust to help meet charitable commitments, and the LLC now holds 137,500 common shares. Fields also reports additional ownership of ReposiTrak securities, including 3,483,955 common shares held directly, further common shares held through entities such as Riverview Financial Corp., his spouse and Fields Management, Inc., and Series B Preferred Stock held indirectly through Riverview Financial Corp. and his spouse.
ReposiTrak, Inc. insider filing shows planned charitable-related stock sales by entities associated with CEO and 10% owner Randall K. Fields. A Rule 10b5-1 trading plan for RK Fields Charitable 2022, LLC executed sales of ReposiTrak common stock on three days: 1,000 shares on 01/14/2026 at a weighted average price of $11.094, 3,600 shares on 01/15/2026 at $11.0786, and 2,900 shares on 01/16/2026 at $10.8452. The trading plan was established to help the reporting person meet charitable commitments.
After these transactions, RK Fields Charitable 2022, LLC held 145,000 shares of common stock. As of 01/14/2026, Randall K. Fields also beneficially owned 3,483,955 common shares directly, plus additional common and Series B preferred stock indirectly through Riverview Financial Corp., his spouse, Fields Management, Inc., and other related holdings.
ReposiTrak director Robert W. Allen reported selling 8,280 shares of Series B Preferred Stock at $10.70 per share on 12/31/2025. After this transaction, he directly held 22,411 shares of Series B Preferred Stock. He also reported direct ownership of 199,147 shares of common stock, plus indirect holdings of 587,476 common shares through a trust and 2,775 common shares held by his spouse.
ReposiTrak, Inc. insider activity shows several transactions by entities associated with Chief Executive Officer Randall K. Fields, who is also a director and 10% owner. RK Fields Charitable 2022, LLC sold 5,000 shares of common stock on January 5, 2026 at a weighted average price of $12.2686 per share and 2,500 shares on January 6, 2026 at a weighted average price of $11.7238 per share under a pre-arranged Rule 10b5-1 trading plan set up to help meet charitable commitments. After these sales, this LLC held 155,000 and then 152,500 common shares. On December 31, 2025, Riverview Financial Corp and the reporting person’s spouse disposed of 60,411 and 1,402 shares of Series B preferred stock at $10.70 per share, leaving 169,797 and 3,704 preferred shares, respectively. As of that date, Fields also held 3,483,955 common shares directly, plus additional indirect common holdings through Riverview Financial Corp., his spouse, and Fields Management, Inc.
ReposiTrak, Inc. insider Randall K. Fields, who serves as Chief Executive Officer, director, and a 10% owner, reported an automatic sale of company stock. On 12/31/2025, an affiliated entity, RK Fields Charitable 2022, LLC, sold 7,500 shares of common stock at a weighted average price of $12.3449 per share under a pre-established Rule 10b5-1 trading plan. The filing states that this trading plan was set up to help Mr. Fields meet certain charitable commitments. After the reported transaction, Mr. Fields continues to report substantial holdings in ReposiTrak common and preferred stock through multiple entities and family holdings.
ReposiTrak, Inc. director reports stock grant and sales
A director of ReposiTrak, Inc. (TRAK) reported several transactions in the company’s common stock. On November 5, 2025, he acquired 1,265 shares, issued in lieu of cash compensation for his board service for the quarter ended September 30, 2025. On December 22, 2025, he sold 1,641 shares at a weighted average price of $13.1981, and on December 23, 2025 he sold an additional 18,906 shares at a weighted average price of $13.164. After these transactions, he beneficially owned 561,869 shares of ReposiTrak common stock, held directly.